Similar articles

• Mucosal and serum IgA antibodies in pigs following infection with Actinobacillus pleuropneumoniae.

  Loftager MK, Eriksen L, Nielsen R. Loftager MK, et al. Adv Exp Med Biol. 1995;371B:935-8. Adv Exp Med Biol. 1995. PMID: 7502930 No abstract available.
• Protective immunity following immunisation of pigs with aerosol of Actinobacillus pleuropneumoniae serotype 2.

  Loftager MK, Eriksen L, Aasted B, Nielsen R. Loftager MK, et al. Res Vet Sci. 1993 Nov;55(3):281-6. doi: 10.1016/0034-5288(93)90095-w. Res Vet Sci. 1993. PMID: 8284489
• Oral immunization with lung-pathogenic bacteria is protective against defined challenge in a pig aerosol infection model.

  Hensel A, Delventhal S, Windt H, Stockhofe-Zurwieden N, Pabst R, Petzoldt K. Hensel A, et al. Adv Exp Med Biol. 1995;371B:803-6. Adv Exp Med Biol. 1995. PMID: 7502901 No abstract available.
• Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.

  Dubreuil JD, Jacques M, Mittal KR, Gottschalk M. Dubreuil JD, et al. Anim Health Res Rev. 2000 Dec;1(2):73-93. doi: 10.1017/s1466252300000074. Anim Health Res Rev. 2000. PMID: 11708600 Review.
• New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.

  Loera-Muro A, Angulo C. Loera-Muro A, et al. Vet Microbiol. 2018 Apr;217:66-75. doi: 10.1016/j.vetmic.2018.02.028. Epub 2018 Mar 6. Vet Microbiol. 2018. PMID: 29615259 Review.